Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
Roche’s R&D rethink hits 20% of molecules as cancer drugs axed
The culls are part of a broader refocusing that has removed 20% of new molecules from the pipeline in recent quarters.
Nick Paul Taylor
Apr 24, 2024 4:27am
As pharma eyes shiny obesity drugs, Vertex tops orphan drug list
Apr 24, 2024 12:01am
Sponsored
Cloud-Based Technology Supports Complex Supply Chains
Apr 22, 2024 8:00am
How Vertex became the VIP of Alpine's exclusive data room
Apr 23, 2024 11:19am
Sponsored
Patient Access and Affordability: PhRMA shares how we can put patients first
Feb 12, 2024 8:00am
Neurocrine-Takeda antidepressant hits main mark in phase 2 trial
Apr 23, 2024 10:44am